Clinical Trial Update: TSO in Pediatric Autistic Spectrum Disorders [Phase 2]

View source ↗

Summary

This clinical trial update notes that a Phase 2 study of TSO for pediatric autism spectrum disorders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• TSO

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Autistic Spectrum Disorders | Phase 2 | Status: TERMINATED